Sustained Improvements in Workplace and Household Productivity and Social Participation With Certolizumab Pegol Over 96 Weeks in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarth ...
Abstract
Authors
der Heijde D. van J. Braun M. Rudwaleit O. Purcaru A. Kavanaugh